| For: | Mathew R. Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1. World J Cardiol 2014; 6(8): 692-705 [PMID: 25228949 DOI: 10.4330/wjc.v6.i8.692] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v6/i8/692.htm |
| Number | Citing Articles |
| 1 |
Xutong Sun, Qing Lu, Manivannan Yegambaram, Sanjiv Kumar, Ning Qu, Anup Srivastava, Ting Wang, Jeffrey R. Fineman, Stephen M. Black. TGF-β1 attenuates mitochondrial bioenergetics in pulmonary arterial endothelial cells via the disruption of carnitine homeostasis. Redox Biology 2020; 36 doi: 10.1016/j.redox.2020.101593
|
| 2 |
Christelle Lteif, Paula Wachs, Ravindra K. Sharma, Julio D. Duarte. The role of Id genes on pulmonary hypertension development in left heart failure. American Heart Journal Plus: Cardiology Research and Practice 2026; 61 doi: 10.1016/j.ahjo.2025.100692
|
| 3 |
Yohei Mineharu, Susumu Miyamoto. RNF213 and GUCY1A3 in Moyamoya Disease: Key Regulators of Metabolism, Inflammation, and Vascular Stability. Frontiers in Neurology 2021; 12 doi: 10.3389/fneur.2021.687088
|
| 4 |
Mirolyuba Ilieva, Shizuka Uchida. Potential Involvement of LncRNAs in Cardiometabolic Diseases. Genes 2023; 14(1) doi: 10.3390/genes14010213
|
| 5 |
Francesco Giangregorio, Emilio Mosconi, Maria Grazia Debellis, Stella Provini, Ciro Esposito, Matteo Garolfi, Simona Oraka, Olga Kaloudi, Gunel Mustafazade, Raquel Marín-Baselga, Yale Tung-Chen. A Systematic Review of Metabolic Syndrome: Key Correlated Pathologies and Non-Invasive Diagnostic Approaches. Journal of Clinical Medicine 2024; 13(19) doi: 10.3390/jcm13195880
|
| 6 |
Kirsten B. Dorschel, John E. Wanebo. Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases. Frontiers in Neurology 2023; 14 doi: 10.3389/fneur.2023.661611
|
| 7 |
Dong‐xin Sui, Hui‐min Zhou, Feng Wang, Ming Zhong, Wei Zhang, Yun Ti. Cell death‐inducing DFF45‐like effector C gene silencing alleviates pulmonary vascular remodeling in a type 2 diabetic rat model. Journal of Diabetes Investigation 2018; 9(4) doi: 10.1111/jdi.12768
|
| 8 |
Suvasini Lakshmanan, Matthew Jankowich, Wen‐Chih Wu, Siddique Abbasi, Alan R Morrison, Gaurav Choudhary. Association of plasma adiponectin with pulmonary hypertension, mortality and heart failure in African Americans: Jackson Heart Study. Pulmonary Circulation 2020; 10(4) doi: 10.1177/2045894020961242
|
| 9 |
Julie A Dillard, Claire Murray, Amit A Mathur. New Therapeutic Targets in Neonatal Pulmonary Hypertension. Newborn 2022; 1(1) doi: 10.5005/jp-journals-11002-0015
|
| 10 |
Hongyan Peng, Yunbin Xiao, Xicheng Deng, Jingfei Luo, Chenliang Hong, Xuping Qin. The Warburg effect: A new story in pulmonary arterial hypertension. Clinica Chimica Acta 2016; 461 doi: 10.1016/j.cca.2016.07.017
|
| 11 |
Gusty Rizky Teguh Ryanto, Ratoe Suraya, Tatsuya Nagano. Mitochondrial Dysfunction in Pulmonary Hypertension. Antioxidants 2023; 12(2) doi: 10.3390/antiox12020372
|
| 12 |
Yu G Birulina, V V Ivanov, E E Buyko, V V Bykov, A V Nosarev, V S Gusakova, S V Gusakova. Pulmonary vascular smooth muscle contraction in the rat model of metabolic syndrome. IOP Conference Series: Earth and Environmental Science 2020; 548(4) doi: 10.1088/1755-1315/548/4/042036
|
| 13 |
Norbert F. Voelkel, Rasa Tamosiuniene, Mark R. Nicolls. Challenges and opportunities in treating inflammation associated with pulmonary hypertension. Expert Review of Cardiovascular Therapy 2016; 14(8) doi: 10.1080/14779072.2016.1180976
|
| 14 |
Sophie Herbert, Robert M. R. Tulloh. Cardiovascular Genetics and Genomics. 2018; doi: 10.1007/978-3-319-66114-8_26
|
| 15 |
Wei Zheng Zhang. Pharmacological Targets in Metabolic Diseases. 2026; doi: 10.1016/B978-0-443-27370-4.00012-3
|